Get started
Author

Dongying Liao

Full-Length Transcriptome Survey and Expression Analysis of Cassia obtusifolia to Discover Putative Genes Related to Aurantio-Obtusin Biosynthesis, Seed Formation and Development, and Stress Response
2018 · Yin Deng, Hui Zheng, et al. · International Journal of Molecular Sciences · 57
Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms
2023 · Fanming Kong, Chaoran Wang, et al. · Chinese Herbal Medicines · 49
Maintenance treatment in advanced HER2-negative gastric cancer
2020 · Y. Yao, R. Deng, et al. · Clinical & Translational Oncology · 16
Ferroptosis in renal fibrosis: a mini-review
2024 · Si-Qi Yang, Xi Zhao, et al. · Journal of drug targeting · 15
Advances in Immunotherapy of Malignant Pleural Mesothelioma
2021 · Dongying Liao, Yongchao Yu, et al. · OncoTargets and Therapy · 11
PDF
Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance
2021 · Fanming Kong, Ziwei Wang, et al. · Frontiers in Oncology · 9
PDF
Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
2022 · Na Wang, Qingyun Mei, et al. · Frontiers in Oncology · 8
PDF
Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma
2024 · Yidan Sun, Qianqian Ma, et al. · The Clinical Respiratory Journal · 5
PDF
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
2023 · Jin Wang, Dongying Liao, et al. · Breast Cancer Targets and Therapy · 5
PDF
Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
2022 · Yongchao Yu, Jin Wang, et al. · Breast Cancer Targets and Therapy · 4
PDF
ADCY4 promotes brain metastasis in small cell lung cancer and is associated with energy metabolism
2024 · Yidan Sun, Yixun Chen, et al. · Heliyon · 3
HER3-targeting Antibody-drug Conjugates Therapy for Solid Tumors: Recent Advances and Future Potentials
2025 · Xuerui Wang, Linlin Zhao, et al. · Current Medicinal Chemistry · 2
Maintenance anlotinib improves the survival prognosis of extensive-stage small cell lung cancer: a single-arm, prospective, phase II study.
2023 · Fanming Kong, Ziwei Wang, et al. · PubMed · 2
PDF
Efficacy and safety of Zhizi-Chi decoction (Gardenia and Fermented Soybean Decoction) for mental disorders: a systematic review and meta-analysis of randomized controlled trials
2025 · Zhenzhen Li, Zhenxin Bao, et al.
PDF
P3.12.01 Phase II Trial of First-Line Double-Dose Firmonertinib in Locally Advanced or Metastatic NSCLC With EGFR L858R (FIRM Study)
2025 · M. Shi, B. Shen, et al. · Journal of Thoracic Oncology
EP13.03-05 Anlotinib as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer: A Single-arm, Prospective, Phase II Study
2023 · F. Kong, Z. Wang, et al. · Journal of Thoracic Oncology
PDF
Xiaoyan granule plus aptinib in patients with advanced gastric cancer who failed radiotherapy and chemotherapy: A prospective, phase II trial
2023 · Fanming Kong, Na Wang, et al. · Research Square
PDF
Adcy4, as a Potential Predictor of Brain Metastasis and Immunotherapy Response in Small Cell Lung Cancer, is Associated with Energy Metabolism
2023 · Yidan Sun, Xin Zhang, et al. · SSRN Electronic Journal
Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges
2022 · Lu Zhao, Jing Zhang, et al. · Anti-Cancer Drugs
Research Progress on RET Fusion in Non-Small-Cell Lung Cancer
2022 · Lu Zhao, Qingyun Mei, et al. · Frontiers in Oncology
PDF
Explain the relationship between the theory of spleen viscera and the pathogenesis of malignant tumors from the perspective of system theory
2021 · JinHui Zuo, Jun Chang, et al. · TMR Cancer - Cancer Advances
Xiaoyan decoction inhibits tumor growth and improves the immunity of mouse with A549 lung carcinoma xenograft
2019 · FanMing Kong, Yang Yao, et al. · TMR Cancer - Cancer Advances
Works count: 22
Citation count: 186
H-index: 7
I10-index: 5
Year
Topic
Type